Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Venetoclax resistance: mechanistic insights and future strategies. | Cancer Drug Resist | 2022 | 35800373 | PubTator, text mining | PubMed |
| 21q22 amplification detection in three patients with acute myeloid leukemia: cytogenomic profiling and literature review. | Mol Cytogenet | 2022 | 35799207 | PubTator, text mining | PubMed |
| CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis. | Leuk Res Rep | 2022 | 35795468 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia. | Mol Ther Oncolytics | 2022 | 35795094 | PubTator, text mining | PubMed |
| Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm. | Cancer Manag Res | 2022 | 35789956 | PubTator, text mining | PubMed |
| Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects. | Nat Med | 2022 | 35788175 | PubTator, text mining | PubMed |
| Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm. | Blood Cancer J | 2022 | 35788129 | PubTator, text mining | PubMed |
| The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors. | Nat Commun | 2022 | 35781533 | PubTator, text mining | PubMed |
| A UHM-ULM interface with unusual structural features contributes to U2AF2 and SF3B1 association for pre-mRNA splicing. | J Biol Chem | 2022 | 35780835 | PubTator, text mining | PubMed |
| Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study. | Transl Oncol | 2022 | 35777247 | PubTator, text mining | PubMed |
| Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms. | Front Oncol | 2022 | 35774119 | PubTator, text mining | PubMed |
| A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation. | RNA | 2022 | 35768279 | PubTator, text mining | PubMed |
| Genetic mutations associated with blood count abnormalities in myeloid neoplasms. | Hematology | 2022 | 35766510 | PubTator, text mining | PubMed |
| Dysregulated minor intron splicing in cancer. | Cancer Sci | 2022 | 35766428 | PubTator, text mining | PubMed |
| Secondary structures in RNA synthesis, splicing and translation. | Comput Struct Biotechnol J | 2022 | 35765654 | PubTator, text mining | PubMed |
| Mutations in the miR-142 gene are not common in myeloproliferative neoplasms. | Sci Rep | 2022 | 35764886 | PubTator, text mining | PubMed |
| Target Therapies for Systemic Mastocytosis: An Update. | Pharmaceuticals (Basel) | 2022 | 35745657 | PubTator, text mining | PubMed |
| Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome. | Cancers (Basel) | 2022 | 35740649 | PubTator, text mining | PubMed |
| CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML. | Cancers (Basel) | 2022 | 35740508 | PubTator, text mining | PubMed |
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. | BMC Med Genomics | 2022 | 35739536 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=46